Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,193 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
ERP44 could serve as a bridge mediating prognosis and immunity for glioma via single-cell and bulk RNA-sequencing (2024-09-26)
-
Two novel heterozygous HPDL variants in a Chinese family with a neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities (2024-10-19)
Journal: GENE (2024) IF: 2.6Products Cited: Penicillin-Streptomycin Solution, 100 ×, MEM/F12 Medium -
C2C12 myoblasts differentiate into myofibroblasts via the TGF-β1 signaling pathway mediated by Fibulin2 (2024-10-28)
Journal: GENE (2024) IF: 2.6Products Cited: C2C12 Cell Complete Medium -
VNN2 regulates hepatic steroid synthesis in response to dietary changes (2024-11-27)
Journal: GENE (2024) IF: 2.6Products Cited: Fetal Bovine Serum, William's E, with L-alanyl-glutamine Medium -
NRAV promoted the malignant progression of gastric cancer (2024-11-29)
Journal: GENE (2024) IF: 2.6Products Cited: GES-1 Cells Line, BGC-823 Cells Line -
SLC12A9 is an immunological and prognostic biomarker for glioma (2024-11-30)
Journal: GENE (2024) IF: 2.6Products Cited: Penicillin-Streptomycin Solution, 100 × -
Transcriptomic analysis of key genes and signaling pathways in sepsis-associated intestinal mucosal barrier damage (2024-11-29)
Journal: GENE (2024) IF: 2.6 -
CARM1-induced lncRNA NEAT1 synchronously activates MYCN and GalNAcT-I to accelerate the progression of neuroblastoma (2024-12-14)
Journal: GENE (2024) IF: 2.6Products Cited: Penicillin-Streptomycin Solution, 100 ×, Ham's F-12 Medium -
The regulation of the cell cycle and epithelial-mesenchymal transition through FUCA2/GGH signaling promotes the progression of lung adenocarcinoma (2024-12-20)
Journal: GENE (2024) IF: 2.6Products Cited: DMEM (High glucose) Medium -
POU4F1 enhances lung cancer gemcitabine resistance by regulating METTL3-dependent TWF1 mRNA N6 adenosine methylation (2024-12-12)
